Head and Neck Cancers Lip
2 clinical trials · Condition
◉ Watch Head and Neck Cancers Lip
| Record | Firm | Date |
|---|---|---|
| VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (NCT03556228) | VM Oncology, LLC | 2018-06-08 |
| Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors (NCT01137162) | Stanford University | 2008-08-01 |
Track Head and Neck Cancers Lip automatically
Every clearance here is in the API, with alerts when new ones post.